Related Experiment Video
Updated: Jun 23, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Advancements in adenoviral based virotherapy for ovarian cancer
Kellie S Matthews1, Ronald D Alvarez, David T Curiel
1The Division of Gynecologic Oncology, The University of Alabama at Birmingham, 619 19th Street South, OHB 534, Birmingham, AL 35213, USA. ksmatthews13@gmail.com
Abstract:
Ovarian cancer is a leading gynecologic malignancy with relatively grim survival statistics. There is a significant need for the development of new treatment options for this malignancy. The development of virotherapy as a treatment option for ovarian cancer has the potential to improve patient survival. Adenoviruses have multiple advantages as vectors for virotherapy including a well-understood structure and the ability to infect cells easily. We will outline the advances in virotherapy in the treatment of ovarian cancer, with particular attention directed toward adenoviral vectors.
Insights
Virotherapy shows promise for treating ovarian cancer, a deadly gynecologic malignancy. Adenoviruses are effective vectors for delivering this novel treatment, potentially improving patient survival rates.
Area of Science:
- Gynecologic Oncology
- Viral Oncology
- Gene Therapy
Background:
- Ovarian cancer presents poor survival outcomes, necessitating novel therapeutic strategies.
- Current treatments for ovarian cancer are limited, highlighting the need for innovative approaches.
- Virotherapy offers a potential new avenue for improving ovarian cancer patient survival.
Purpose of the Study:
- To review advancements in virotherapy for ovarian cancer treatment.
- To highlight the potential of adenoviral vectors in ovarian cancer virotherapy.
- To discuss the advantages of adenoviruses as vectors in cancer treatment.
Main Methods:
- Literature review of virotherapy research in ovarian cancer.
- Focus on adenoviral vector applications and characteristics.
- Analysis of current and emerging virotherapy strategies.
Main Results:
- Adenoviruses possess advantageous properties for virotherapy, including a well-defined structure.
- Adenoviruses demonstrate efficient cellular infection capabilities, crucial for oncolytic activity.
- Virotherapy research is progressing, with adenoviral vectors showing significant promise.
Conclusions:
- Virotherapy, particularly using adenoviral vectors, represents a promising frontier in ovarian cancer treatment.
- The unique properties of adenoviruses make them suitable candidates for developing effective ovarian cancer virotherapies.
- Further research into adenoviral virotherapy could lead to improved outcomes for ovarian cancer patients.
More Related Videos
11:13Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
Published on: April 7, 2016
06:16Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models
Published on: March 16, 2022
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against specific...